Co-Authors
This is a "connection" page, showing publications co-authored by Elena Bartoloni and Roberto Gerli.
Connection Strength
8.971
-
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? Cardiovasc Res. 2020 11 01; 116(13):e193-e194.
Score: 0.911
-
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study. J Clin Med. 2019 Apr 19; 8(4).
Score: 0.819
-
Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter? Front Immunol. 2019; 10:817.
Score: 0.819
-
Effect of Sinovial High-Low® injections in trapeziometacarpal osteoarthritis. Clin Exp Rheumatol. 2019 Jan-Feb; 37(1):166.
Score: 0.800
-
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? Front Cardiovasc Med. 2018; 5:177.
Score: 0.799
-
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome. Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):113-120.
Score: 0.770
-
Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol. 2018 Jan; 15(1):33-44.
Score: 0.730
-
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'. Ann Rheum Dis. 2021 Jan 28.
Score: 0.232
-
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience. Front Med (Lausanne). 2020; 7:608728.
Score: 0.229
-
Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia. 2020; 58(5):261-264.
Score: 0.227
-
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020 08; 68(4):213-224.
Score: 0.224
-
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):754-759.
Score: 0.224
-
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart. Clin Exp Rheumatol. 2020 May-Jun; 38(3):580.
Score: 0.220
-
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020 07; 111:102468.
Score: 0.219
-
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome. Clin Exp Rheumatol. 2019 May-Jun; 37 Suppl 118(3):192-198.
Score: 0.210
-
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? Clin Exp Rheumatol. 2019 May-Jun; 37 Suppl 118(3):133-139.
Score: 0.210
-
A Platelet's Guide to Synovitis. Isr Med Assoc J. 2019 Jul; 21(7):454-459.
Score: 0.208
-
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome. Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):210-214.
Score: 0.195
-
Novel Therapeutic Strategies in Primary Sjögren's Syndrome. Isr Med Assoc J. 2017 Sep; 19(9):576-580.
Score: 0.183
-
Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):73-79.
Score: 0.181
-
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study. Autoimmun Rev. 2017 Mar; 16(3):253-257.
Score: 0.176
-
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections. Microorganisms. 2021 Jan 07; 9(1).
Score: 0.058
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol. 2019 May-Jun; 37 Suppl 118(3):97-106.
Score: 0.052
-
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response. Front Pharmacol. 2019; 10:296.
Score: 0.051
-
Platelets Contribute to the Accumulation of Matrix Metalloproteinase Type 2 in Synovial Fluid in Osteoarthritis. Thromb Haemost. 2017 11; 117(11):2116-2124.
Score: 0.047
-
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study. Front Pharmacol. 2017; 8:369.
Score: 0.045
-
Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor? Front Immunol. 2017; 8:554.
Score: 0.045
-
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue. J Rheumatol. 2017 08; 44(8):1179-1183.
Score: 0.045
-
Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome. Clin Exp Rheumatol. 2017 May-Jun; 35(3):546-547.
Score: 0.044